Pipeline
A focused pipeline, by design.
Activome's pipeline centers on a single lead program: a gene- and protein-restoration therapy built to restore the regulators of tissue regeneration that decline with age.
Lead program
Regenerative restoration therapy
- Modality
- Gene- and protein-restoration therapy
- Therapeutic focus
- Sarcopenia, neurodegenerative disease, and age-related functional decline
- Aim
- Restore the regulators of tissue regeneration that decline with age
- Status
- Early development
Development stage
Current development stage: Discovery and Preclinical, of five stages — Discovery, Preclinical, Phase 1, Phase 2, and Phase 3.
Focus areas
Where the lead program is aimed.
| Program | Area of focus | Modality | Stage |
|---|---|---|---|
| Lead program | Sarcopenia & age-related muscle loss | Gene / protein restoration | Discovery / Preclinical |
| Lead program | Alzheimer's disease & other neurodegenerative disorders | Gene / protein restoration | Discovery / Preclinical |
| Lead program | Age-related functional decline | Gene / protein restoration | Discovery / Preclinical |
Please note. The stages shown reflect a single program in early development. They do not represent clinical trials, regulatory submissions, or established safety or efficacy, and are subject to change as the science advances.
Partnering
Interested in what we're building?
We welcome inquiries from scientific collaborators, strategic partners, and investors interested in our approach.
Contact us